Advance Nanotech CEO Magnus Gittins to Present at Think Equity Conference in San Francisco.

NEW YORK -- Advance Nanotech, Inc., (OTC BB: AVNA), the world's premier provider of services, support and financing to drive the commercialization of nanotechnology discoveries, today announced that CEO Magnus Gittins will present a corporate overview to potential investors at the Think Equity Partners Third Annual Growth Conference on Monday, September 12, 2005. The conference will take place at the Ritz Carlton Hotel in San Francisco at 3pm PDT. For more information on the conference please visit http://www.thinkequity.com/about/conf_Growth_05.html

Advance Nanotech is currently funding 20 portfolio companies in the electronics, biopharma, and materials industries. The firm provides services ranging from funding, to human capital and research equipment essential to ensuring that the most promising companies can accelerate the path to rapid commercialization. In this way, investor exposure to any particular technology is mitigated with Advance Nanotech retaining the option to increase investment in those technologies that successfully mature.

About ThinkEquity Partners LLC

ThinkEquity Partners LLC is a research-centric institutional investment firm focused on the growth economy. ThinkEquity Partners LLC is dedicated to providing focused insight, advisory services, and capital to institutional investors and corporate constituents in the knowledge economy's key growth verticals, including technology, healthcare, media and consumer business services. For more information about ThinkEquity Partners LLC, please visit www.thinkequity.com. Member NASD and SIPC.

About Advance Nanotech, Inc.

Advance Nanotech Inc. is dedicated to ensuring nanotechnology discoveries reach maximum market potential through successful commercialization. Advance is the trusted guide to commercial success for nanotech entrepreneurs spanning the globe, partnering with leading universities to provide scientists and researchers with mission critical infrastructure support to transform their discoveries to marketable solutions. The organization provides a range of services and support including financing, leadership assets, and counsel on intellectual property, licensing and regulatory issues. With a portfolio of more than 20 companies developing technologies which offer potentially breakthrough nanotechnology discoveries in the electronics, biopharma and materials sectors, Advance's goal is to transform the potential for nanotechnology discoveries into innovative products that further evolve existing industries and enable new markets.